Vyzulta Side Effects
Generic name: latanoprostene bunod ophthalmic
Medically reviewed by Drugs.com. Last updated on May 28, 2024.
Note: This document provides detailed information about Vyzulta Side Effects associated with latanoprostene bunod ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Vyzulta.
Applies to latanoprostene bunod ophthalmic: ophthalmic solution.
Serious side effects of Vyzulta
Along with its needed effects, latanoprostene bunod ophthalmic (the active ingredient contained in Vyzulta) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking latanoprostene bunod ophthalmic:
More common side effects
- redness of the white part of the eyes or the inside of the eyelids
Less common side effects
- eye irritation
Rare side effects
- painful irritation of the clear front part of the eye swelling of the eye and the lining of the eyelid
Incidence not known
- blurred vision or other change in vision
- decreased vision
- eye pain
- redness of the eye
- sensitivity of the eye to light
- tearing
Other side effects of Vyzulta
Some side effects of latanoprostene bunod ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Rare side effects
- feeling of having something in the eye
Incidence not known
- increased brown color in the colored part of the eye longer, thicker, and darker eyelashes
For healthcare professionals
Applies to latanoprostene bunod ophthalmic: ophthalmic solution.
General adverse events
The most frequently reported side effects were conjunctival hyperemia, eye irritation, eye pain, and instillation site pain.[Ref]
Ocular
- Common (1% to 10%): Conjunctival hyperemia, eye irritation, eye pain, instillation site pain
- Frequency not reported: Foreign body sensation, punctate keratitis, vision blurred, conjunctival edema, conjunctival irritation[Ref]
About 0.6% of patients discontinued therapy due to ocular adverse reactions including ocular hyperemia, conjunctival irritation, eye irritation, eye pain, conjunctival edema, vision blurred, punctate keratitis, and foreign body sensation.[Ref]
References
1. (2017) "Product Information. Vyzulta (latanoprostene bunod ophthalmic)." Bausch and Lomb Americas, Inc.
More about Vyzulta (latanoprostene bunod ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Vyzulta side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.